Guidance is presented for understanding the impact of potassium and phosphorus additives on people with chronic kidney disease (CKD) and managing their consumption.
Ignoring albuminuria testing may lead to systematic underdiagnosis of chronic kidney disease, leaving millions of patients at ...
Sustainable diets for veterans with chronic kidney disease require careful consideration for past military experiences, ...
11don MSN
New kidney health guidance on impact and management of potassium and phosphorus additives released
The American Society of Nephrology (ASN) today released its latest Kidney Health Guidance (KHG) addressing how potassium and ...
Siloed care and duplicated costs mean we’re failing people with multiple chronic conditions. Clinically guided ...
“The results from the present study encourage urgent strategic action through policy implementation that would lead to ...
A new study published in the journal of Diabetes Research and Clinical Practice showed that proliferative diabetic ...
The use of retinal images can help investigators noninvasively identify chronic kidney disease and assess patient prognosis. The risk-adjusted 1-year mortality rate was not different between Medicare ...
Arch acquires a new CKD platform that has the potential to produce next-generation CKD drugs for the pharmaceutical industryBased on a novel ...
ProKidney shows strong Phase 2 CKD data, FDA support, and cash runway, with key readouts ahead despite single-asset risks.
Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the CKD ...
Hanmi Pharmaceutical's "Efeglenatide," the first domestically developed GLP-1 (glucagon-like peptide-1) obesity drug in Korea, is set to expand its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback